Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges
International Journal of Nanomedicine · 2024-07 · Volume 19 · 7415-7471
DOI: 10.2147/ijn.s460047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2024-07. Verfasst von Xixi Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: NMPA Key Laboratory for Quality Research and Control of Tissue Regenerative Biomaterial, & Institute of Regulatory Science for Medical Device, & Nati…. Hauptthemen laut MEDLINE: Neoplasms, Nanomedicine, Antineoplastic Agents, Liposomes. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 353 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NMPA Key Laboratory for Quality Research and Control of Tissue Regenerative Biomaterial, & Institute of Regulatory Science for Medical Device, & National Engineering Research Center for Biomaterials, Sichuan University,…
ORCID-Profile: Qiang Ao
Zitieren
APA
Wu, X., Xin, Y., Zhang, H., Quan, L., & Ao, Q. (2024). Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges. International Journal of Nanomedicine, Volume 19, 7415-7471. https://doi.org/10.2147/ijn.s460047
Vancouver
Wu X, Xin Y, Zhang H, Quan L, Ao Q. Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges. International Journal of Nanomedicine. 2024;Volume 19:7415-7471. doi:10.2147/ijn.s460047
BibTeX
@article{Wu2024,
author = {Wu, Xixi and Xin, Yuan and Zhang, Hengtong and Quan, Liang and Ao, Qiang},
title = {Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges},
journal = {International Journal of Nanomedicine},
year = {2024},
volume = {Volume 19},
pages = {7415--7471},
doi = {10.2147/ijn.s460047}
}
EUVIMED